Fat, iron and fibrosis are important features of liver disease that commonly coexist. Emerging quantitative MRI biomarkers including proton density fat fraction (PDFF), R2*/R2 and T1 enable quantification of fat, iron, and fibrosis, respectively, and require quantitative MR phantoms for validation and quality assurance. Although current phantoms enable separate adjustment of PDFF, R2*/R2 or T1, there is an unmet need for phantoms that accurately mimic MRI signals in the presence of simultaneous fat, iron and fibrosis by jointly controlling PDFF, R2*/R2 and T1. In this work, we develop and validate a novel phantom that jointly controls PDFF, R2*/R2 and T1.
This abstract and the presentation materials are available to members only; a login is required.